We performed a prospective study on a CF cohort at baseline health, monitoring gene panel measurements, spirometry, quantitative sputum microbiology, CRP and sputum neutrophil elastase before and after one month of AZLI. This evidence concerns the gene CRP and cystic fibrosis.